Financhill
Buy
82

DOCS Quote, Financials, Valuation and Earnings

Last price:
$58.23
Seasonality move :
-0.88%
Day range:
$57.51 - $58.93
52-week range:
$22.96 - $61.75
Dividend yield:
0%
P/E ratio:
66.98x
P/S ratio:
22.58x
P/B ratio:
11.32x
Volume:
982.9K
Avg. volume:
2.3M
1-year change:
108.7%
Market cap:
$10.9B
Revenue:
$475.4M
EPS (TTM):
$0.87

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
DOCS
Doximity
$127.2M $0.26 12.82% 39.65% $55.24
DRIO
DarioHealth
$7.4M -$0.18 104.95% -60.98% --
FOXO
FOXO Technologies
-- -- -- -- --
OTRK
Ontrak
$2.6M -- -13% -- --
SPOK
Spok Holdings
$34.3M $0.24 4.56% 18.18% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
DOCS
Doximity
$58.27 $55.24 $10.9B 66.98x $0.00 0% 22.58x
DRIO
DarioHealth
$0.70 -- $23.9M -- $0.00 0% 1.09x
FOXO
FOXO Technologies
$0.25 -- $4.3M -- $0.00 0% 1.85x
OTRK
Ontrak
$1.45 -- $6.1M -- $0.00 0% 0.50x
SPOK
Spok Holdings
$15.96 -- $323.5M 21.86x $0.31 7.83% 2.37x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
DOCS
Doximity
-- 2.833 -- 7.03x
DRIO
DarioHealth
33.03% 1.132 82.25% 1.27x
FOXO
FOXO Technologies
224.55% 16.543 1241.69% 0.06x
OTRK
Ontrak
40.88% 4.227 95.85% 0.98x
SPOK
Spok Holdings
-- 0.265 -- 1.08x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
DOCS
Doximity
$123.2M $55.4M 19.29% 19.29% 40.52% $66.8M
DRIO
DarioHealth
$3.9M -$12M -49.97% -71.65% -162.06% -$7.4M
FOXO
FOXO Technologies
$655K -$1.1M -- -- -83.28% $576K
OTRK
Ontrak
$1.6M -$5.1M -149.3% -231.34% -198.72% -$1.4M
SPOK
Spok Holdings
$27.7M $5.3M 9.13% 9.13% 15.31% $10.3M

Doximity vs. Competitors

  • Which has Higher Returns DOCS or DRIO?

    DarioHealth has a net margin of 32.27% compared to Doximity's net margin of -166.11%. Doximity's return on equity of 19.29% beat DarioHealth's return on equity of -71.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    90.01% $0.22 $961.2M
    DRIO
    DarioHealth
    52.23% -$0.25 $87.4M
  • What do Analysts Say About DOCS or DRIO?

    Doximity has a consensus price target of $55.24, signalling downside risk potential of -5.21%. On the other hand DarioHealth has an analysts' consensus of -- which suggests that it could grow by 400.07%. Given that DarioHealth has higher upside potential than Doximity, analysts believe DarioHealth is more attractive than Doximity.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    4 13 0
    DRIO
    DarioHealth
    3 0 0
  • Is DOCS or DRIO More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.468, suggesting its more volatile than the S&P 500 by 46.822%.

  • Which is a Better Dividend Stock DOCS or DRIO?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or DRIO?

    Doximity quarterly revenues are $136.8M, which are larger than DarioHealth quarterly revenues of $7.4M. Doximity's net income of $44.2M is higher than DarioHealth's net income of -$12.3M. Notably, Doximity's price-to-earnings ratio is 66.98x while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 22.58x versus 1.09x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    22.58x 66.98x $136.8M $44.2M
    DRIO
    DarioHealth
    1.09x -- $7.4M -$12.3M
  • Which has Higher Returns DOCS or FOXO?

    FOXO Technologies has a net margin of 32.27% compared to Doximity's net margin of -162.71%. Doximity's return on equity of 19.29% beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    90.01% $0.22 $961.2M
    FOXO
    FOXO Technologies
    54.77% -$0.15 $14M
  • What do Analysts Say About DOCS or FOXO?

    Doximity has a consensus price target of $55.24, signalling downside risk potential of -5.21%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Doximity has higher upside potential than FOXO Technologies, analysts believe Doximity is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    4 13 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is DOCS or FOXO More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock DOCS or FOXO?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or FOXO?

    Doximity quarterly revenues are $136.8M, which are larger than FOXO Technologies quarterly revenues of $1.2M. Doximity's net income of $44.2M is higher than FOXO Technologies's net income of -$1.9M. Notably, Doximity's price-to-earnings ratio is 66.98x while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 22.58x versus 1.85x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    22.58x 66.98x $136.8M $44.2M
    FOXO
    FOXO Technologies
    1.85x -- $1.2M -$1.9M
  • Which has Higher Returns DOCS or OTRK?

    Ontrak has a net margin of 32.27% compared to Doximity's net margin of -217.21%. Doximity's return on equity of 19.29% beat Ontrak's return on equity of -231.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    90.01% $0.22 $961.2M
    OTRK
    Ontrak
    62.05% -$1.77 $19.4M
  • What do Analysts Say About DOCS or OTRK?

    Doximity has a consensus price target of $55.24, signalling downside risk potential of -5.21%. On the other hand Ontrak has an analysts' consensus of -- which suggests that it could grow by 175.86%. Given that Ontrak has higher upside potential than Doximity, analysts believe Ontrak is more attractive than Doximity.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    4 13 0
    OTRK
    Ontrak
    0 0 0
  • Is DOCS or OTRK More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ontrak has a beta of 2.569, suggesting its more volatile than the S&P 500 by 156.857%.

  • Which is a Better Dividend Stock DOCS or OTRK?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or OTRK?

    Doximity quarterly revenues are $136.8M, which are larger than Ontrak quarterly revenues of $2.6M. Doximity's net income of $44.2M is higher than Ontrak's net income of -$5.6M. Notably, Doximity's price-to-earnings ratio is 66.98x while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 22.58x versus 0.50x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    22.58x 66.98x $136.8M $44.2M
    OTRK
    Ontrak
    0.50x -- $2.6M -$5.6M
  • Which has Higher Returns DOCS or SPOK?

    Spok Holdings has a net margin of 32.27% compared to Doximity's net margin of 10.5%. Doximity's return on equity of 19.29% beat Spok Holdings's return on equity of 9.13%.

    Company Gross Margin Earnings Per Share Invested Capital
    DOCS
    Doximity
    90.01% $0.22 $961.2M
    SPOK
    Spok Holdings
    79.54% $0.18 $156.3M
  • What do Analysts Say About DOCS or SPOK?

    Doximity has a consensus price target of $55.24, signalling downside risk potential of -5.21%. On the other hand Spok Holdings has an analysts' consensus of -- which suggests that it could fall by -6.02%. Given that Spok Holdings has more downside risk than Doximity, analysts believe Doximity is more attractive than Spok Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    DOCS
    Doximity
    4 13 0
    SPOK
    Spok Holdings
    0 0 0
  • Is DOCS or SPOK More Risky?

    Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.334, suggesting its less volatile than the S&P 500 by 66.63%.

  • Which is a Better Dividend Stock DOCS or SPOK?

    Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.83% to investors and pays a quarterly dividend of $0.31 per share. Doximity pays -- of its earnings as a dividend. Spok Holdings pays out 163.68% of its earnings as a dividend.

  • Which has Better Financial Ratios DOCS or SPOK?

    Doximity quarterly revenues are $136.8M, which are larger than Spok Holdings quarterly revenues of $34.9M. Doximity's net income of $44.2M is higher than Spok Holdings's net income of $3.7M. Notably, Doximity's price-to-earnings ratio is 66.98x while Spok Holdings's PE ratio is 21.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 22.58x versus 2.37x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    DOCS
    Doximity
    22.58x 66.98x $136.8M $44.2M
    SPOK
    Spok Holdings
    2.37x 21.86x $34.9M $3.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 25

Power Solutions International [PSIX] is up 27.42% over the past day.

Buy
65
TSLL alert for Dec 25

Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.

Buy
75
SMLR alert for Dec 25

Semler Scientific [SMLR] is up 15.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock